![Logo for Lyell Immunopharma Inc](/_next/image?url=https%3A%2F%2Ffiles.quartr.com%2Fcompany-logos%2F0f67b-2022-12-10-01-06-52.png&w=256&q=100)
Lyell Immunopharma Investor Relations Material
Latest events
![Logo for Lyell Immunopharma Inc](/_next/image?url=https%3A%2F%2Ffiles.quartr.com%2Fcompany-logos%2F0f67b-2022-12-10-01-06-52.png&w=128&q=100)
Study Update
Lyell Immunopharma
Access the full event backlog
Slides, Transcripts, and Reports from 9,000+ public companies
Latest reports from Lyell Immunopharma Inc
Access all reports
Lyell Immunopharma Inc., a T cell reprogramming company, engages in developing T cell therapies for patients with solid tumors. It develops BioPulse treatment which modulates the expression of tumor antigens to amplify cellular immunotherapy. The company offers B-chimeric antigen receptor (CAR) to stimulate infiltration of T cells into cancer cells. Its cytokine treatments include OncoPuls, which aims at generating self-amplifying CAR populations expressing a single target antigen; and UniPuls, which has the potential to express multiple antigens and can be used with conventional chemotherapy formulations. Its other product is intratumoral T cell vaccines, which targets epithelial cancers. The company utilizes its proprietary technologies in the development of novel therapeutics for the treatment of antibody-refractory cancers. It also focuses on the discovery and development of programmable immune cell therapies using Autologous Dendritic Cells (DCs) and T cells; Identification of Biotherapeutics for Cancer; Antibody Directed Selection/Activation of T Cells (ADSTAT); and Novel Cancer Therapeutic Products Development Platforms.
Key slides for Lyell Immunopharma Inc
![Forward Looking Stat](/_next/image?url=https%3A%2F%2Fcdn.quartr.com%2Fimages%2Fconference-calls%2Flyell-immunopharma-inc-study-update-3ef1bb328b9b9a20%2F2.png&w=3840&q=75)
![Logo for Lyell Immunopharma Inc](/_next/image?url=https%3A%2F%2Ffiles.quartr.com%2Fcompany-logos%2F0f67b-2022-12-10-01-06-52.png&w=128&q=100)
Study Update
Lyell Immunopharma Inc
![Patient Characterist](/_next/image?url=https%3A%2F%2Fcdn.quartr.com%2Fimages%2Fconference-calls%2Flyell-immunopharma-inc-study-update-3ef1bb328b9b9a20%2F11.png&w=3840&q=75)
![Logo for Lyell Immunopharma Inc](/_next/image?url=https%3A%2F%2Ffiles.quartr.com%2Fcompany-logos%2F0f67b-2022-12-10-01-06-52.png&w=128&q=100)
Study Update
Lyell Immunopharma Inc
Latest articles
![Key](/_next/image?url=https%3A%2F%2Fa.storyblok.com%2Ff%2F182663%2F1882x1059%2F7e17876154%2Fbirkin.png&w=3840&q=75)
The Birkin Bag: The Story Behind the World's Most Desired Handbag
How the Birkin bag became the world's most sought-after handbag where even the wealthy must earn the right to own one.
12 Jul 2024
![Key](/_next/image?url=https%3A%2F%2Fa.storyblok.com%2Ff%2F182663%2F2688x1512%2F8365aa8316%2Ftop-10-largest-semiconductor-companies.png&w=3840&q=75)
The 10 Largest Semiconductor Companies in the World
Discover the top 10 semiconductor companies by market cap, exploring their innovations and business models shaping the tech landscape.
10 Jul 2024
![Key](/_next/image?url=https%3A%2F%2Fa.storyblok.com%2Ff%2F182663%2F2000x1125%2F135c0e3f6b%2Fthe-rise-of-nubank.png&w=3840&q=75)
The Rise of Nubank: Changing Latin American Finance
Discover how Nubank revolutionized Latin American banking with innovation, backed by top investors like Berkshire Hathaway.
9 Jul 2024
Ticker symbol
LYEL
Country
🇺🇸 United States